SPDR S&P Biotech ETF (XBI)

Latest stories mapped to XBI

• 2026-09-18 The Biotech Surged 50% On Positive Data In March. Now, It's Almost Gone.
• 2026-09-18 Exclusive-US weighs allowing most pharma licensing deals with China, sources say
• 2026-09-17 Why is Xenon Pharmaceuticals stock plunging today?
• 2026-09-17 Xenon drops after pausing enrollment in azetukalner studies for depression
• 2026-09-17 Ultragenyx stock surges 10% on FDA approval for gene therapy
• 2026-09-17 Aethlon Medical to merge with North Immunology in all-stock deal
• 2026-09-17 Citizens reiterates Foghorn Therapeutics stock rating on trial data
• 2026-09-15 William Blair initiates Zentalis stock with outperform rating
• 2026-09-15 Top SMid Biotechnology Stocks: JPMorgan’s Latest Pick
• 2026-09-15 PTC Therapeutics at Morgan Stanley conference: sephience drives outlook
• 2026-09-15 Why is Rocket Pharmaceuticals stock down 5% today?
• 2026-09-15 BlossomHill stock surges on positive lung cancer trial data
• 2026-09-14 Intellia at Morgan Stanley conference: launch path and cash runway
• 2026-09-14 Kymera Therapeutics at H.C. Wainwright: oral drug push gains pace
• 2026-09-14 Contineum Therapeutics stock falls on phase 2 trial miss
• 2026-09-14 Stifel reiterates Cullinan Oncology stock Buy rating on trial data
• 2026-09-14 Moderna at Morgan Stanley conference: oncology gains and vaccine growth
• 2026-09-14 Electra Therapeutics targets $977.6 million valuation in US IPO